(Rac)-Indoximod(Synonyms: 1-Methyl-DL-tryptophan; (Rac)-NLG-8189)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

(Rac)-Indoximod (Synonyms: 1-Methyl-DL-tryptophan; (Rac)-NLG-8189) 纯度: 98.13%

(Rac)-Indoximod (1-Methyl-DL-tryptophan) 是吲哚胺-2,3-双加氧酶 (IDO) 抑制剂。(Rac)-Indoximod 和 IFN-γ 联用显著降低了表达 α-SMA 的人心肌成纤维细胞活性，并通过上调 IRF-1，Fas 和 FasL 基因诱导凋亡(apoptosis)。

(Rac)-Indoximod(Synonyms: 1-Methyl-DL-tryptophan; (Rac)-NLG-8189)

(Rac)-Indoximod Chemical Structure

CAS No. : 26988-72-7

规格 价格 是否有货 数量
10 mM * 1 mL in Water ￥610 In-stock
50 mg ￥550 In-stock
100 mg   询价  
200 mg   询价  

* Please select Quantity before adding items.

(Rac)-Indoximod 相关产品

•相关化合物库:

  • Bioactive Compound Library Plus
  • Apoptosis Compound Library
  • Immunology/Inflammation Compound Library
  • Metabolism/Protease Compound Library
  • Anti-Cancer Compound Library
  • Small Molecule Immuno-Oncology Compound Library

生物活性

(Rac)-Indoximod (1-Methyl-DL-tryptophan) is an indoleamine 2,3-dioxygenase (IDO) inhibitor. Co-treatment with IFN-γ and (Rac)-Indoximod markedly reduces the activity of human cardiac myofibroblasts (hCMs) expressing α-SMA and induces apoptosis through up-regulating the IRF-1, Fas, and FasL genes[1].

IC50 & Target[1]

IDO

 

体外研究
(In Vitro)

(Rac)-Indoximod (1-Methyl-DL-tryptophan; 0.5 mM; 3 days) inhibits tryptophan depletion, thereby partially reversing the growth-inhibitory activity of IFN-γ, but eventually induces cell death regardless of tryptophan depletion[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Human cardiac myofibroblasts (hCMs)
Concentration: 0.5 mM
Incubation Time: 3 days
Result: Growth retardation by IFN-γ was partially reversed on day 2, but cell viability was further reduced on day 3.

分子量

218.25

Formula

C12H14N2O2
CAS 号

26988-72-7
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶解性数据
In Vitro: 

H2O : 2.5 mg/mL (11.45 mM; ultrasonic and warming and adjust pH to 10 with NaOH and heat to 60°C)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 4.5819 mL 22.9095 mL 45.8190 mL
5 mM 0.9164 mL 4.5819 mL 9.1638 mL
10 mM 0.4582 mL 2.2910 mL 4.5819 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
参考文献

  • [1]. Jun-Won Lee,et al. Co-treatment with interferon-γ and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis. Mol Cell Biochem. 2019 Aug;458(1-2):197-205.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务